title: Effect of retinoic acid and delta-like 1 homologue (DLK1) on differentiation in neuroblastoma.
abstract: The principal objective of this study was to evaluate the chemopreventive and therapeutic effects of a combination of all-trans-retinoic acid (RA) and knockdown of delta-like 1 homologue (Drosophila) (DLK1) on neuroblastoma, the most common malignant disease in children. As unfavorable neuroblastoma is poorly differentiated, neuroblastoma cell was induced differentiation by RA or DLK1 knockdown. Neuroblastoma cells showed elongated neurite growth, a hallmark of neuronal differentiation at various doses of RA, as well as by DLK1 knockdown. In order to determine whether or not a combination of RA and DLK1 knockdown exerts a greater chemotherapeutic effect on neuroblastoma, cells were incubated at 10 nM RA after being transfected with SiRNA-DLK1. Neuronal differentiation was increased more by a combination of RA and DLK1 knockdown than by single treatment. Additionally, in order to assess the signal pathway of neuroblastoma differentiation induced by RA and DLK1 knockdown, treatment with the specific MEK/ERK inhibitors, U0126 and PD 98059, was applied to differentiated neuroblastoma cells. Differentiation induced by RA and DLK1 knockdown increased ERK phosphorylation. The MEK/ERK inhibitor U0126 completely inhibited neuronal differentiation induced by both RA and DLK1 knockdown, whereas PD98059 partially blocked neuronal differentiation. After the withdrawal of inhibitors, cellular differentiation was fully recovered. This study is, to the best of our knowledge, the first to demonstrate that the specific inhibitors of the MEK/ERK pathway, U0126 and PD98059, exert differential effects on the ERK phosphorylation induced by RA or DLK1 knockdown. Based on the observations of this study, it can be concluded that a combination of RA and DLK1 knockdown increases neuronal differentiation for the control of the malignant growth of human neuroblastomas, and also that both MEK1 and MEK2 are required for the differentiation induced by RA and DLK1 knockdown.
authors.affiliation: Department of Nutritional Science and Food Management, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea.
authors.forename: Yuri
authors.initials: Y
authors.lastname: Kim
references.citation: Clin Cancer Res. 1996 Mar;2(3):511-20
references.pmid: 9816198
references.citation: Differentiation. 2000 Aug;66(1):49-59
references.pmid: 10997592
references.citation: World J Surg. 2005 Mar;29(3):317-24
references.pmid: 15706435
references.citation: J Biol Chem. 1993 Feb 25;268(6):3817-20
references.pmid: 8095043
references.citation: J Nucl Med. 2004 Jul;45(7):1172-88
references.pmid: 15235064
references.citation: Brain Res. 2009 Feb 23;1256:8-18
references.pmid: 19135033
references.citation: J Biol Chem. 2000 Apr 21;275(16):11915-20
references.pmid: 10766819
references.citation: Methods Mol Biol. 2000;99:161-75
references.pmid: 10909084
references.citation: Mol Cancer Ther. 2007 Apr;6(4):1425-32
references.pmid: 17431121
references.citation: Oncogene. 2005 Jun 23;24(27):4472-6
references.pmid: 15806146
references.citation: Histochem Cell Biol. 1996 Dec;106(6):535-42
references.pmid: 8985741
references.citation: J Clin Oncol. 1999 Jul;17(7):2264-79
references.pmid: 10561284
references.citation: J Immunol. 2000 Jan 1;164(1):256-64
references.pmid: 10605019
references.citation: Int J Cancer. 2003 May 20;105(1):61-9
references.pmid: 12672031
references.citation: Oncogene. 2006 Mar 23;25(13):1852-61
references.pmid: 16288219
references.citation: Cell. 1995 Jan 27;80(2):225-36
references.pmid: 7834742
references.citation: Histol Histopathol. 2000 Jan;15(1):119-29
references.pmid: 10668203
references.citation: Mol Cell Biol. 2005 Apr;25(8):3040-55
references.pmid: 15798192
references.citation: J Biol Chem. 1998 Jul 17;273(29):18623-32
references.pmid: 9660836
references.citation: Leukemia. 2005 Aug;19(8):1404-10
references.pmid: 15959531
references.citation: Lancet Oncol. 2008 Mar;9(3):247-56
references.pmid: 18308250
references.citation: Science. 1965 Aug 20;149(3686):879-80
references.pmid: 14332853
references.citation: Cancer Res. 2009 Dec 15;69(24):9271-80
references.pmid: 19934310
references.citation: Horm Metab Res. 2002 Nov-Dec;34(11-12):664-70
references.pmid: 12660879
references.citation: J Biol Chem. 1995 Nov 17;270(46):27489-94
references.pmid: 7499206
references.citation: Clin Cancer Res. 2001 Oct;7(10):2955-7
references.pmid: 11595682
references.citation: Leukemia. 2000 Aug;14(8):1371-7
references.pmid: 10942231
references.citation: Methods Enzymol. 2001;332:417-31
references.pmid: 11305115
references.citation: Blood. 1999 Aug 15;94(4):1192-200
references.pmid: 10438706
references.citation: Mol Cell Biol. 1998 Sep;18(9):5247-55
references.pmid: 9710609
references.citation: Biochem J. 2000 Oct 1;351(Pt 1):95-105
references.pmid: 10998351
references.citation: Nat Rev Cancer. 2003 Mar;3(3):203-16
references.pmid: 12612655
references.citation: J Cell Biochem. 2004 Jun 1;92(3):525-33
references.pmid: 15156564
references.citation: FEBS Lett. 2004 Feb 27;560(1-3):178-82
references.pmid: 14988019
references.citation: J Neurobiol. 2006 Jun;66(7):606-30
references.pmid: 16688755
references.citation: Genome Biol. 2006;7(9):R84
references.pmid: 16989664
references.citation: Cell. 1993 May 21;73(4):725-34
references.pmid: 8500166
references.citation: J Clin Oncol. 1997 Feb;15(2):790-5
references.pmid: 9053506
references.citation: J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S128-30
references.pmid: 18520295